Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.19% | 72.25 | 0.9% | $620.88m | |
| CELG | Celgene Corporation | 0.00% | 127.65 | 1.1% | $445.33m | |
| AMGN | Amgen Inc. | 0.10% | 167.45 | 1.1% | $418.88m | |
| BIIB | Biogen Inc. | 0.08% | 281.98 | 1.2% | $356.65m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.20% | 468.93 | 2.7% | $322.48m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.24% | 148.48 | 1.9% | $265.22m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.66% | 134.28 | 1.9% | $219.41m | |
| ILMN | Illumina, Inc. | 0.42% | 190.12 | 3.5% | $217.26m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.30% | 36.81 | 19.8% | $138.86m | |
| INCY | Incyte Corporation | -1.48% | 119.40 | 2.6% | $129.02m | |
| CLVS | Clovis Oncology, Inc. | -0.56% | 71.56 | 18.0% | $128.48m | |
| KITE | Kite Pharma, Inc. | 1.13% | 131.65 | 16.1% | $123.22m | |
| TSRO | TESARO, Inc. | -0.09% | 113.76 | 14.7% | $121.57m | |
| A | Agilent Technologies, Inc. | 0.56% | 61.59 | 1.5% | $119.69m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.04% | 80.95 | 4.4% | $108.62m |
Company Profile
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.